The latest study on Companion Diagnostic Tests in Oncology Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Companion Diagnostic Tests in Oncology Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Companion Diagnostic Tests in Oncology and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Abbott
Roche
Genomic Health
QIAGEN
Agilent
Agendia
BioMerieux
Illumina
Siemens Healthcare
Thermo Fisher
Companion Diagnostic Tests in Oncology Market Analysis By Type Segment:
Protein Detection
DNA Detection
Companion Diagnostic Tests in Oncology Market Analysis By Application Segment:
Pharmaceutical & Biotechnology Companies
Medical Device Companies
Research Institutes
Companion Diagnostic Tests in Oncology Market Analysis By Regions (Countries):
The Companion Diagnostic Tests in Oncology Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Companion Diagnostic Tests in Oncology Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Companion Diagnostic Tests in Oncology Market:
Companion Diagnostic Tests in Oncology market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Companion Diagnostic Tests in Oncology Market status and future forecast.
To present the key Companion Diagnostic Tests in Oncology Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type (2016-2027)
1.4.2 Protein Detection
1.4.3 DNA Detection
1.5 Market by Application
1.5.1 Global Companion Diagnostic Tests in Oncology Market Share by Application (2016-2027)
1.5.2 Pharmaceutical & Biotechnology Companies
1.5.3 Medical Device Companies
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Companion Diagnostic Tests in Oncology Market Size
2.2 Companion Diagnostic Tests in Oncology Growth Trends by Regions
2.2.1 Companion Diagnostic Tests in Oncology Market Size by Regions (2016-2027)
2.2.2 Companion Diagnostic Tests in Oncology Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Companion Diagnostic Tests in Oncology Market Size by Manufacturers
3.1.1 Global Companion Diagnostic Tests in Oncology Revenue by Manufacturers (2020)
3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Manufacturers (2020)
3.1.3 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI)
3.2 Companion Diagnostic Tests in Oncology Key Players Head office and Area Served
3.3 Key Players Companion Diagnostic Tests in Oncology Product/Solution/Service
3.4 Date of Enter into Companion Diagnostic Tests in Oncology Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Companion Diagnostic Tests in Oncology Market Size by Type (2016-2020)
4.2 Global Companion Diagnostic Tests in Oncology Market Size by Application (2016-2020)
5 United States
5.1 United States Companion Diagnostic Tests in Oncology Market Size (2016-2020)
5.2 Companion Diagnostic Tests in Oncology Key Players in United States
5.3 United States Companion Diagnostic Tests in Oncology Market Size by Type
5.4 United States Companion Diagnostic Tests in Oncology Market Size by Application
6 Europe
6.1 Europe Companion Diagnostic Tests in Oncology Market Size (2016-2020)
6.2 Companion Diagnostic Tests in Oncology Key Players in Europe
6.3 Europe Companion Diagnostic Tests in Oncology Market Size by Type
6.4 Europe Companion Diagnostic Tests in Oncology Market Size by Application
7 China
7.1 China Companion Diagnostic Tests in Oncology Market Size (2016-2020)
7.2 Companion Diagnostic Tests in Oncology Key Players in China
7.3 China Companion Diagnostic Tests in Oncology Market Size by Type
7.4 China Companion Diagnostic Tests in Oncology Market Size by Application
8 Japan
8.1 Japan Companion Diagnostic Tests in Oncology Market Size (2016-2020)
8.2 Companion Diagnostic Tests in Oncology Key Players in Japan
8.3 Japan Companion Diagnostic Tests in Oncology Market Size by Type
8.4 Japan Companion Diagnostic Tests in Oncology Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Companion Diagnostic Tests in Oncology Market Size (2016-2020)
9.2 Companion Diagnostic Tests in Oncology Key Players in Southeast Asia
9.3 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type
9.4 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application
10 India
10.1 India Companion Diagnostic Tests in Oncology Market Size (2016-2020)
10.2 Companion Diagnostic Tests in Oncology Key Players in India
10.3 India Companion Diagnostic Tests in Oncology Market Size by Type
10.4 India Companion Diagnostic Tests in Oncology Market Size by Application
11 Central & South America
11.1 Central & South America Companion Diagnostic Tests in Oncology Market Size (2016-2020)
11.2 Companion Diagnostic Tests in Oncology Key Players in Central & South America
11.3 Central & South America Companion Diagnostic Tests in Oncology Market Size by Type
11.4 Central & South America Companion Diagnostic Tests in Oncology Market Size by Application
12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Companion Diagnostic Tests in Oncology Introduction
12.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2020)
12.1.5 Abbott Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Companion Diagnostic Tests in Oncology Introduction
12.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2020)
12.2.5 Roche Recent Development
12.3 Genomic Health
12.3.1 Genomic Health Company Details
12.3.2 Company Description and Business Overview
12.3.3 Companion Diagnostic Tests in Oncology Introduction
12.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2020)
12.3.5 Genomic Health Recent Development
12.4 QIAGEN
12.4.1 QIAGEN Company Details
12.4.2 Company Description and Business Overview
12.4.3 Companion Diagnostic Tests in Oncology Introduction
12.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2020)
12.4.5 QIAGEN Recent Development
12.5 Agilent
12.5.1 Agilent Company Details
12.5.2 Company Description and Business Overview
12.5.3 Companion Diagnostic Tests in Oncology Introduction
12.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2020)
12.5.5 Agilent Recent Development
12.6 Agendia
12.6.1 Agendia Company Details
12.6.2 Company Description and Business Overview
12.6.3 Companion Diagnostic Tests in Oncology Introduction
12.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2020)
12.6.5 Agendia Recent Development
12.7 BioMerieux
12.7.1 BioMerieux Company Details
12.7.2 Company Description and Business Overview
12.7.3 Companion Diagnostic Tests in Oncology Introduction
12.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2020)
12.7.5 BioMerieux Recent Development
12.8 Illumina
12.8.1 Illumina Company Details
12.8.2 Company Description and Business Overview
12.8.3 Companion Diagnostic Tests in Oncology Introduction
12.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2020)
12.8.5 Illumina Recent Development
12.9 Siemens Healthcare
12.9.1 Siemens Healthcare Company Details
12.9.2 Company Description and Business Overview
12.9.3 Companion Diagnostic Tests in Oncology Introduction
12.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2020)
12.9.5 Siemens Healthcare Recent Development
12.10 Thermo Fisher
12.10.1 Thermo Fisher Company Details
12.10.2 Company Description and Business Overview
12.10.3 Companion Diagnostic Tests in Oncology Introduction
12.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2020)
12.10.5 Thermo Fisher Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Companion Diagnostic Tests in Oncology Key Market Segments
Table Key Players Companion Diagnostic Tests in Oncology Covered
Table Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type 2016-2027
Figure Protein Detection Figures
Table Key Players of Protein Detection
Figure DNA Detection Figures
Table Key Players of DNA Detection
Table Global Companion Diagnostic Tests in Oncology Market Size Growth by Application 2016-2027 (Million US$)
Figure Pharmaceutical & Biotechnology Companies Case Studies
Figure Medical Device Companies Case Studies
Figure Research Institutes Case Studies
Figure Companion Diagnostic Tests in Oncology Report Years Considered
Table Global Companion Diagnostic Tests in Oncology Market Size 2016-2027 (Million US$)
Figure Global Companion Diagnostic Tests in Oncology Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Companion Diagnostic Tests in Oncology Market Size by Regions 2016-2027 (Million US$)
Table Global Companion Diagnostic Tests in Oncology Market Size by Regions 2016-2020 (Million US$)
Table Global Companion Diagnostic Tests in Oncology Market Share by Regions 2016-2020
Figure Global Companion Diagnostic Tests in Oncology Market Share by Regions 2016-2020
Figure Global Companion Diagnostic Tests in Oncology Market Share by Regions 2020
Table Market Top Trends
Table Global Companion Diagnostic Tests in Oncology Revenue by Manufacturers (2020) (Million US$)
Table Global Companion Diagnostic Tests in Oncology Market Share by Manufacturers (2020)
Figure Global Companion Diagnostic Tests in Oncology Market Share by Manufacturers in 2020
Table Global Companion Diagnostic Tests in Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Companion Diagnostic Tests in Oncology Product/Solution/Service
Table Date of Enter into Companion Diagnostic Tests in Oncology Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Companion Diagnostic Tests in Oncology Market Size by Type (2016-2020) (Million US$)
Table Global Companion Diagnostic Tests in Oncology Market Size Share by Type (2016-2020)
Figure Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2016-2020)
Table Global Companion Diagnostic Tests in Oncology Market Size by Application (2016-2020) (Million US$)
Table Global Companion Diagnostic Tests in Oncology Market Size Share by Application (2016-2020)
Figure Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2016-2020)
Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application in 2020
Figure United States Companion Diagnostic Tests in Oncology Market Size 2016-2020 (Million US$)
Table United States Key Players Companion Diagnostic Tests in Oncology Revenue (2020) (Million US$)
Table United States Key Players Companion Diagnostic Tests in Oncology Market Share (2020)
Table United States Companion Diagnostic Tests in Oncology Market Size by Type (2016-2020) (Million US$)
Table United States Companion Diagnostic Tests in Oncology Market Share by Type (2016-2020)
Table United States Companion Diagnostic Tests in Oncology Market Size by Application (2016-2020) (Million US$)
Table United States Companion Diagnostic Tests in Oncology Market Share by Application (2016-2020)
Figure Europe Companion Diagnostic Tests in Oncology Market Size 2016-2020 (Million US$)
Table Europe Key Players Companion Diagnostic Tests in Oncology Revenue (2020) (Million US$)
Table Europe Key Players Companion Diagnostic Tests in Oncology Market Share (2020)
Table Europe Companion Diagnostic Tests in Oncology Market Size by Type (2016-2020) (Million US$)
Table Europe Companion Diagnostic Tests in Oncology Market Share by Type (2016-2020)
Table Europe Companion Diagnostic Tests in Oncology Market Size by Application (2016-2020) (Million US$)
Table Europe Companion Diagnostic Tests in Oncology Market Share by Application (2016-2020)
Figure China Companion Diagnostic Tests in Oncology Market Size 2016-2020 (Million US$)
Table China Key Players Companion Diagnostic Tests in Oncology Revenue (2020) (Million US$)
Table China Key Players Companion Diagnostic Tests in Oncology Market Share (2020)
Table China Companion Diagnostic Tests in Oncology Market Size by Type (2016-2020) (Million US$)
Table China Companion Diagnostic Tests in Oncology Market Share by Type (2016-2020)
Table China Companion Diagnostic Tests in Oncology Market Size by Application (2016-2020) (Million US$)
Table China Companion Diagnostic Tests in Oncology Market Share by Application (2016-2020)
Figure Japan Companion Diagnostic Tests in Oncology Market Size 2016-2020 (Million US$)
Table Japan Key Players Companion Diagnostic Tests in Oncology Revenue (2020) (Million US$)
Table Japan Key Players Companion Diagnostic Tests in Oncology Market Share (2020)
Table Japan Companion Diagnostic Tests in Oncology Market Size by Type (2016-2020) (Million US$)
Table Japan Companion Diagnostic Tests in Oncology Market Share by Type (2016-2020)
Table Japan Companion Diagnostic Tests in Oncology Market Size by Application (2016-2020) (Million US$)
Table Japan Companion Diagnostic Tests in Oncology Market Share by Application (2016-2020)
Figure Southeast Asia Companion Diagnostic Tests in Oncology Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Companion Diagnostic Tests in Oncology Revenue (2020) (Million US$)
Table Southeast Asia Key Players Companion Diagnostic Tests in Oncology Market Share (2020)
Table Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Type (2016-2020)
Table Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Application (2016-2020)
Figure India Companion Diagnostic Tests in Oncology Market Size 2016-2020 (Million US$)
Table India Key Players Companion Diagnostic Tests in Oncology Revenue (2020) (Million US$)
Table India Key Players Companion Diagnostic Tests in Oncology Market Share (2020)
Table India Companion Diagnostic Tests in Oncology Market Size by Type (2016-2020) (Million US$)
Table India Companion Diagnostic Tests in Oncology Market Share by Type (2016-2020)
Table India Companion Diagnostic Tests in Oncology Market Size by Application (2016-2020) (Million US$)
Table India Companion Diagnostic Tests in Oncology Market Share by Application (2016-2020)
Figure Central & South America Companion Diagnostic Tests in Oncology Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Companion Diagnostic Tests in Oncology Revenue (2020) (Million US$)
Table Central & South America Key Players Companion Diagnostic Tests in Oncology Market Share (2020)
Table Central & South America Companion Diagnostic Tests in Oncology Market Size by Type (2016-2020) (Million US$)
Table Central & South America Companion Diagnostic Tests in Oncology Market Share by Type (2016-2020)
Table Central & South America Companion Diagnostic Tests in Oncology Market Size by Application (2016-2020) (Million US$)
Table Central & South America Companion Diagnostic Tests in Oncology Market Share by Application (2016-2020)
Table Abbott Company Details
Table Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2020) (Million US$)
Figure Abbott Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020)
Table Abbott Recent Development
Table Roche Company Details
Table Roche Revenue in Companion Diagnostic Tests in Oncology Business (2020)(Million US$)
Figure Roche Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020)
Table Roche Recent Development
Table Genomic Health Company Details
Table Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2020)(Million US$)
Figure Genomic Health Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020)
Table Genomic Health Recent Development
Table QIAGEN Company Details
Table QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2020)(Million US$)
Figure QIAGEN Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020)
Table QIAGEN Recent Development
Table Agilent Company Details
Table Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2020)(Million US$)
Figure Agilent Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020)
Table Agilent Recent Development
Table Agendia Company Details
Table Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2020)(Million US$)
Figure Agendia Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020)
Table Agendia Recent Development
Table BioMerieux Company Details
Table BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2020)(Million US$)
Figure BioMerieux Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020)
Table BioMerieux Recent Development
Table Illumina Company Details
Table Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2020)(Million US$)
Figure Illumina Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020)
Table Illumina Recent Development
Table Siemens Healthcare Company Details
Table Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2020)(Million US$)
Figure Siemens Healthcare Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020)
Table Siemens Healthcare Recent Development
Table Thermo Fisher Company Details
Table Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2020)(Million US$)
Figure Thermo Fisher Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020)
Table Thermo Fisher Recent Development
Table Global Companion Diagnostic Tests in Oncology Market Size by Regions (Million US$) 2021-2027
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Regions (2021-2027)
Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Regions in 2027
Figure United States Companion Diagnostic Tests in Oncology Market Size Forecast (2021-2027)(Million USD)
Figure Europe Companion Diagnostic Tests in Oncology Market Size Forecast (2021-2027)(Million USD)
Figure China Companion Diagnostic Tests in Oncology Market Size Forecast (2021-2027)(Million USD)
Figure Japan Companion Diagnostic Tests in Oncology Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Companion Diagnostic Tests in Oncology Market Size Forecast (2021-2027)(Million USD)
Figure India Companion Diagnostic Tests in Oncology Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Companion Diagnostic Tests in Oncology Market Size Forecast (2021-2027)(Million USD)
Table Global Companion Diagnostic Tests in Oncology Market Size by Product (2021-2027) (Million US$)
Figure Global Companion Diagnostic Tests in Oncology Market Size by Product (2021-2027)
Figure Global Companion Diagnostic Tests in Oncology Market Size by Product in 2027
Table Global Companion Diagnostic Tests in Oncology Market Size by Application (2021-2027) (Million US$)
Figure Global Companion Diagnostic Tests in Oncology Market Size by Application (2021-2027)
Figure Global Companion Diagnostic Tests in Oncology Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources